Journal of Experimental Medicine, Vol 167, 694-699, Copyright © 1988 by Rockefeller University Press

ARTICLES

A unique V-J-C-rearranged gene encodes a gamma protein expressed on the majority of CD3+ T cell receptor-alpha/beta- circulating lymphocytes

F Triebel, F Faure, M Graziani, S Jitsukawa, MP Lefranc and T Hercend
Departement de Biologie Clinique, Institut Gustave-Roussy, Villejuif, France.

We have recently described an mAb, anti-Ti gamma A, that recognizes an antigenic determinant carried by a TCR gamma chain. This antibody binds to approximately 3% of human PBLs and delineates a CD2+, CD3+, TCR- alpha/beta-, CD4-, CD8+/-, CD5+, NKH1-, and HLA class II- subset. The present study was designed to identify the gene encoding the Ti gamma A epitope. A first analysis was carried out on a previously characterized TCR gamma + fetal-cloned cell line termed F6C7. It was found that F6C7 cells have one gamma rearrangement on each chromosome: one joins V gamma 3 to J gamma 1, and the second joins V gamma 9 to J gamma P. Because only the latter allele appeared to be transcribed in the F6C7 lymphocytes, these data strongly suggested that anti-Ti gamma A mAb is specific for either a V gamma 9 or a V gamma 9-J gamma P-encoded peptide. To confirm this point, we studied an additional series of 13 randomly selected Ti gamma A+ cloned cells derived from peripheral blood of three distinct adult individuals. Each one of these lymphocytes was shown to both possess and transcribe a V gamma 9-J gamma P-C gamma 1-rearranged gene. It is therefore concluded that a predominant subpopulation of CD3+ TCR-alpha/beta- human circulating T lymphocytes (namely, the subset defined by anti-Ti gamma A mAb) surface expresses a gamma protein with a limited potential of variability from one cell to another.
CiteULike    Complore    Connotea    Del.icio.us    Digg    Facebook    Reddit    Technorati    Twitter    What's this?

This article has been cited by other articles:

• Oyoshi, M. K., Nagata, H., Kimura, N., Zhang, Y., Demachi, A., Hara, T., Kanegane, H., Matsuo, Y., Yamaguchi, T., Morio, T., Hirano, A., Shimizu, N., Yamamoto, K. (2003). Preferential Expansion of V{gamma}9-J{gamma}P/V{delta}2-J{delta}3 {gamma}{delta} T Cells in Nasal T-Cell Lymphoma and Chronic Active Epstein-Barr Virus Infection. Am. J. Pathol. 162: 1629-1638 [Abstract] [Full Text]  
• Hviid, L., Kurtzhals, J. A. L., Adabayeri, V., Loizon, S., Kemp, K., Goka, B. Q., Lim, A., Mercereau-Puijalon, O., Akanmori, B. D., Behr, C. (2001). Perturbation and Proinflammatory Type Activation of V{delta}1+ {gamma}{delta} T Cells in African Children with Plasmodium falciparum Malaria. Infect. Immun. 69: 3190-3196 [Abstract] [Full Text]  
• Nagata, H., Konno, A., Kimura, N., Zhang, Y., Kimura, M., Demachi, A., Sekine, T., Yamamoto, K., Shimizu, N. (2001). Characterization of novel natural killer (NK)-cell and {gamma}{delta} T-cell lines established from primary lesions of nasal T/NK-cell lymphomas associated with the Epstein-Barr virus. Blood 97: 708-713 [Abstract] [Full Text]  
• Hviid, L., Akanmori, B. D., Loizon, S., Kurtzhals, J. A. L., Ricke, C. H., Lim, A., Koram, K. A., Nkrumah, F. K., Mercereau-Puijalon, O., Behr, C. (2000). High frequency of circulating {gamma}{delta} T cells with dominance of the V{delta}1 subset in a healthy population. Int Immunol 12: 797-805 [Abstract] [Full Text]  
• Fisch, P, Malkovsky, M, Kovats, S, Sturm, E, Braakman, E, Klein, B., Voss, S., Morrissey, L., DeMars, R, Welch, W., et, al. (1990). Recognition by human V gamma 9/V delta 2 T cells of a GroEL homolog on Daudi Burkitt's lymphoma cells. Science 250: 1269-1273 [Abstract]  

Home | Help | Feedback | Subscriptions | Archive | Search

TABLE OF CONTENTS